Corrigendum to "Impact of cancer-associated mutations in CC chemokine receptor 2 on receptor function and antagonism" [Biochem. Pharmacol. 208 (2023) 115399]

Author(s):
Hollander, L.S. den; Béquignon, O.J.M. (0000-0002-7554-9220); Wang, X.; Wezel, K. van; Broekhuis, J.D.; Gorostiola Gonzalez, M. (0000-0003-1568-0881); Visser, K.E. de; IJzerman, A.P. (0000-0002-1182-2259); Westen, G.J.P. van (0000-0003-0717-1817); Heitman, L.H. (0000-0002-1381-8464)
Published
2023
Publication type
Contribution for newspaper or weekly magazine

Abstract

Refers to

Impact of cancer-associated mutations in CC chemokine receptor 2 on receptor function and antagonism

Biochemical Pharmacology, Volume 208, February 2023, Pages 115399 L.S. den Hollander, O.J.M. Béquignon, X. Wang, K. van Wezel, J. Broekhuis, M. Gorostiola González, K.E. de Visser, A.P. IJzerman, G.J.P. van Westen, L.H. Heitman

Date issued
2023-03-31
Language
English
Is part of
Biochemical Pharmacology (2023), Vol. 209, p. 115540, 115450
hdl
1887/3590019
doi
10.1016/j.bcp.2023.115450